{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:09:07Z","timestamp":1787738947943,"version":"build-2784847793"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/pas.0000000000000555","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T12:52:48Z","timestamp":1447764768000},"page":"335-341","source":"Crossref","is-referenced-by-count":60,"title":["Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features"],"prefix":"10.1097","volume":"40","author":[{"given":"Sarah L.","family":"Ondrejka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Grzywacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Bodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Makishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej","family":"Przychodzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International T-Cell Lymphoma Project. International peripheral T-cell and natural killerT-cell lymphoma study: Pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":". Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":". Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","article-title":". Epstein-barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified.","volume":"117","author":"Zettl","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":". Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":". Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): A new diagnostic marker providing evidence that AITL derives from follicular helper T cells.","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3324\/haematol.2009.010991","article-title":". The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.","volume":"95","author":"Marafioti","year":"2010","journal-title":"Haematologica"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":". The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":". Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":". TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":". A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"R14-5-20210131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma.","volume":"366","author":"Couronne","year":"2012","journal-title":"N Engl J Med"},{"key":"R15-5-20210131","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":". IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":". Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":". Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":". A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","article-title":". Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral TNK-cell lymphomas. A North American PTCL study group project.","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":". Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: Clinical correlation and insights into natural history and disease progression.","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":". Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma.","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"R22-5-20210131","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","article-title":". CBL, CBLB, TET2, ASXL1, and IDH12 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.","volume":"117","author":"Makishima","year":"2011","journal-title":"Blood"},{"key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":". Frequent pathway mutations of splicing machinery in myelodysplasia.","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"R24-5-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2011.12.003","article-title":"Rho GTPases: masters of T lymphocyte migration and activation.","volume":"142","author":"Rougerie","year":"2012","journal-title":"Immunol Lett"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nri2606","article-title":"Rho family GTPases and their regulators in lymphocytes.","volume":"9","author":"Tybulewicz","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.194.7.903","article-title":". Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T cell receptor responses in vivo.","volume":"194","author":"Corre","year":"2001","journal-title":"J Exp Med"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng.2937","article-title":"RHOA mutations in peripheral T cell lymphoma.","volume":"46","author":"Cools","year":"2014","journal-title":"Nat Genet"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.onc.1203259","article-title":". Loss of rho function in the thymus is accompanied by the development of thymic lymphoma.","volume":"19","author":"Cleverley","year":"2000","journal-title":"Oncogene"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1096\/fj.09-145102","article-title":". RhoAROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis.","volume":"24","author":"Bryan","year":"2010","journal-title":"FASEB J"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2141.2008.07534.x","article-title":". Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma.","volume":"144","author":"Konstantinou","year":"2009","journal-title":"Br J Haematol"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":". Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:59Z","timestamp":1620967559000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201603000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000555","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}